| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |